Found 6 matching trials
Protect II, A Prospective, Multicenter Randomized Controlled Trial PHASE3 The IMPELLA® 2.5 System will be superior to Intra Aortic Balloon Pump in pr...
Show More Location
University of Alabama
Learn More & Join Trial
MINI-AMI: Minimizing Infarct Size With Impella 2.5 Following PCI for Acute Myocardial Infarction NA A prospective, randomized, controlled multi-site feasibility trial to asses...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparison of Standard Treatment Versus Standard Treatment Plus Extracorporeal Life Support (ECLS) in Myocardial Infarction Complicated With Cardiogenic Shock PHASE4 Cardiogenic shock is currently the main cause of death after myocardial inf...
Show More Location
Brest University Hospital
Learn More & Join Trial
Efficacy Study of LV Assist Device to Treat Patients With Cardiogenic Shock (ISAR-SHOCK) PHASE4 The purpose of this study is to evaluate the efficacy and safety of a left ...
Show More Location
Deutsches Herzzentrum Muenchen
Learn More & Join Trial
PROTECT I, A Prospective Feasibility Trial Investigating the Use of IMPELLA RECOVER LP 2.5 System in Patients Undergoing High Risk PCI PHASE2 The objective of this feasibility study is to demonstrate that the device i...
Show More Learn More & Join Trial
Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability PHASE3 This is a randomized trial investigating the use of the IMPELLA RECOVER LP ...
Show More Location
Hartford Hospital
Learn More & Join Trial